Literature DB >> 15127691

SARS: a quality management test of our public health safety net.

Ron Zapp1, Mel Krajden, Tim Lynch.   

Abstract

Emergence of severe acute respiratory syndrome in March 2003 tested all aspects of BC Centre for Disease Control (BCCDC) operations. In addition to its public health responsibilities, BCCDC was pivotal in the science defining SARS. These events occurred under international scientific and media scrutiny over a 4-month period and were seen as an opportunity to learn about how the Centre performed under extreme pressure as a QM-based (quality-management-based) organization. A retrospective review of the QM practices over the previous 6-months was initiated on June 30, 2003. Key management documentation during the study period was reviewed. Structured interviews were conducted with front line personnel. Customized instrumentation was developed to correlate management decisions with recognized QM criteria: anticipatory management; keeping programs on track; ongoing adjustment, improvement, and revision; identifying and improving sources of error, waste, and redundancy; feedback from key stakeholders; and data-driven decision-making methods. The team structure between laboratory science and epidemiology was critical. This was attributed to the culture of scientific discovery of the organization. All knowledge gained was shared with other organizations around the world. The consensus is that British Columbia was very lucky this time around. This review is part of BCCDC's commitment to fighting emerging infectious diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15127691     DOI: 10.1097/00019514-200404000-00004

Source DB:  PubMed          Journal:  Qual Manag Health Care        ISSN: 1063-8628            Impact factor:   0.926


  2 in total

1.  Controlling droplet-transmitted respiratory infections: best practices and cost.

Authors:  William Hogg; Patricia Huston
Journal:  Can Fam Physician       Date:  2006-10       Impact factor: 3.275

2.  Serology in the Digital Age: Using Long Synthetic Peptides Created from Nucleic Acid Sequences as Antigens in Microarrays.

Authors:  Muhammad Rizwan; Bengt Rönnberg; Maksims Cistjakovs; Åke Lundkvist; Rudiger Pipkorn; Jonas Blomberg
Journal:  Microarrays (Basel)       Date:  2016-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.